Business Wire

1X Announces Strategic Partnership to Make up to 10,000 Humanoid Robots Available to EQT’s Global Portfolio

11.12.2025 15:00:00 CET | Business Wire | Press Release

Share

1X, the AI and robotics company behind NEO, the first ready-to-ship humanoid robot, today announced a strategic partnership with EQT, one of the world’s largest private equity firms and an investor in 1X through EQT Ventures. The partnership marks the beginning of what could become a large-scale commercial rollout of general-purpose humanoid robots across multiple industries.

Together, 1X and EQT have a shared intent to facilitate the rollout of up to 10,000 humanoids across EQT’s global portfolio companies between 2026 and 2030, with any potential implementation decision ultimately taken by each portfolio company. The partnership represents an early step in bringing humanoid robotics into mainstream commercial use.

Through this collaboration, EQT’s portfolio companies will gain early access to 1X’s commercial production capacity and integration expertise, giving early adopters a first-mover advantage in addressing structural workforce transformation. The partnership will focus on high-impact use cases for robots working closely with humans, such as industrial software, logistics, facility operations, warehousing, manufacturing, and healthcare.

1X will launch pilots in the United States in 2026, followed by rapid scaling across Europe and Asia.

“This partnership brings humanoid robotics into the real economy,”said Bernt Øivind Børnich, Founder and CEO of 1X. “EQT’s global reach and operational expertise make them the ideal partner to help deploy our technology safely, responsibly, and at scale. Together, we aim to demonstrate how humanoid robots can enhance productivity, improve safety, and create more sustainable labor models worldwide.”

“Humanoid robotics is moving from fiction to real-world deployment, and 1X is uniquely positioned to lead the next wave of mass-market robotic adoption,” said Ted Persson, lead Partner in EQT Ventures, which first invested in 1X in 2023. This isn’t about replacing people, it’s about giving them superpowers. By making 1X’s technology available to our portfolio companies, we help them tackle labor shortages, improve safety, and unlock new levels of productivity in the industries that keep the world running.”

Key Highlights

  • Up to 10,000 humanoids made available for deployment across EQT’s 300+ portfolio companies (2026–2030), with any potential implementation decided by each portfolio company
  • Focus on logistics, facility operations, warehousing, manufacturing, and healthcare
  • Joint ambition for safe, responsible, and human-centered deployment

The partnership underscores a shared vision between EQT and 1X: a future where humanoid robots work alongside people, supporting industrial resilience and enhancing productivity. With this announcement, 1X strengthens its position as a frontrunner in the global race to commercialize general-purpose humanoid robots at scale.

About 1X

1X is a leading U.S.-based AI and robotics company, developing NEO – the humanoid robot. 1X’s mission is to create an abundant future through safe, intelligent humanoids. The humanoid platform from 1X has been designed to operate amongst humans. From homes to manufacturing floors, 1X provides an artificial labor solution to enhance human potential.

About EQT

EQT is a global investment organization with a clear purpose and €267 billion in assets under management as of 30 September 2025. The platform spans Private Capital and Real Assets and includes about 300 portfolio companies with roughly 700,000 employees. EQT also owns more than 2,000 real estate assets across the US, Europe, and Asia Pacific, including 1,800 logistics tenants and 20,000 living tenants. Its infrastructure portfolio supports 330 million passengers each year, serves 40 million users of social infrastructure services, operates more than 70 data centers, and includes over 145 clinics. More info: www.eqtgroup.com

EQT Ventures

EQT Ventures is an early-stage lead investor striving to be the most impactful partner to generation-defining founders. Since launch, EQT Ventures has raised over €2.6 billion across its funds and partnered with more than 140 founding teams across Europe and the US to build enduring, category-defining companies. The team provides more than capital, offering deep operational expertise, strategic guidance, and access to EQT’s global platform to accelerate growth. With a team of former founders and operators, EQT Ventures delivers radical support to help startups scale with confidence. EQT Ventures is part of EQT Group and, together with EQT Growth, forms EQT’s early-stage tech platform. https://eqtgroup.com/private-capital/eqt-ventures

View source version on businesswire.com: https://www.businesswire.com/news/home/20251211360340/en/

Contacts

Media Contact:
Kendall Pennington
Head of Communications, 1X
Email: press@1x.tech

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Meiji Seika Pharma’s Morcamilast (ME3183) was Granted Orphan Medicinal Product Designation by the European Commission for Palmoplantar Pustulosis3.3.2026 02:00:00 CET | Press Release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that morcamilast (proposed international nonproprietary name; development code: ME3183), a selective phosphodiesterase-4 (PDE4) inhibitor, has been granted orphan medicinal product designation by the European Commission (EC) for the treatment of palmoplantar pustulosis (PPP). Palmoplantar pustulosis is a chronic inflammatory disease characterized by the development of multiple sterile pustules on the palms and soles. Patients often experience pain and pruritus of the skin, and the condition can be accompanied by nail involvement and joint pain. Because lesions on the palms are visible to others and lesions on the soles can cause pain while walking, daily functioning can be significantly restricted, leading in a substantial reduction in quality of life. PPP has a pathophysiology distinct from psoriasis and pustular psoriasis, and treatment can be challenging, unde

Yubico Establishes Singapore as Third Global Headquarters Accelerating Asia Pacific Growth3.3.2026 01:00:00 CET | Press Release

Yubico (NASDAQ STOCKHOLM: YUBICO), a cybersecurity company, inventor of FIDO passkeys and creator of the YubiKey, the most secure passkey, today announced the opening of its third global headquarters in Singapore. This announcement reinforces Yubico’s long-term commitment to the Asia Pacific region and builds on its role in advancing open authentication standards, while shaping a safer digital world for all. The new office complements Yubico’s existing global headquarters in Stockholm, Sweden and Santa Clara, USA, reflecting its strategy to serve a growing international user base by helping customers deploy YubiKeys at scale to adapt to a rapidly evolving cybersecurity landscape. “As the digital economy grows, there’s a decisive shift across Asia Pacific, where organizations are moving beyond legacy multi-factor authentication to meet rigorous new national regulations for identity protection,” said Jerrod Chong, Acting Chief Executive Officer at Yubico, a Singaporean. “The expansion of

IFF Completed the Divestiture of Soy Crush, Concentrates and Lecithin Businesses2.3.2026 22:15:00 CET | Press Release

IFF (NYSE: IFF) today announced that it has successfully completed the previously announced divestiture of its soy crush, concentrates and lecithin businesses to Bunge. This transaction does not include IFF’s soy isolates business. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in taste, scent, food ingredients, health and biosciences, we’re innovating for the future. Every day, we deliver groundbreaking, sustainable solutions that elevate products people love — advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook. © 2026 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved. View source version on businesswire.com: https://www.businesswire.com/news/home/20260302231096/en/

Verimatrix ReAccess Earns Gold 2026 Merit Award for Telecom & Wireless2.3.2026 17:50:00 CET | Press Release

Regulatory News: Verimatrix (Euronext Paris: VMX), a leading provider of security solutions for a safer connected world, today announced that its Verimatrix ReAccess solution was honored with a gold 2026 Merit Award for Telecom & Wireless. The industry accolade recognizes the company’s next-generation content security solution that modernizes legacy Conditional Access Systems (CAS) across DVB, IPTV and OTT networks without requiring costly hardware replacements or field service interventions. Judged by industry executives, media professionals and technology consultants, the Merit Awards evaluate submissions from across the telecommunications landscape. Verimatrix ReAccess enables secure, over-the-air (OTA) software updates to deployed set-top boxes (STBs), delivering operator cost savings, reduced operational complexity, and ongoing protection against piracy. It also empowers operators to continuously strengthen content security, eliminating the need for costly hardware replacements. U

Textron Aviation Launches Donation Campaign to Support 2026 Special Olympics Airlift; Continues Nationwide Call for Volunteer Doves2.3.2026 17:00:00 CET | Press Release

Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, today announced the launch of a donation campaign benefitting Special Olympics in support of the 2026 Special Olympics Airlift, a nationwide effort that brings athletes and coaches to the Special Olympics USA Games through the generosity of volunteer pilots, aircraft owners and operators known as Doves. Financial contributions go directly to the Special Olympics, a 501(c)(3) charitable organization. New for the 2026 event, the donation campaign serves a vital role in ensuring each delegation has what it needs for a smooth and welcoming travel experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302196418/en/ Textron Aviation launches donation campaign to support 2026 Special Olympics Airlift; continues nationwide call for volunteer Doves (Photo credit: Textron Aviation). “This campaign reflects the spirit of unity and generosity that defines the Special Olym

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye